Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$2.63 - $4.12 $19,462 - $30,488
-7,400 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$3.94 - $5.44 $29,156 - $40,256
7,400 New
7,400 $31,000
Q1 2021

May 24, 2021

SELL
$4.61 - $9.04 $1,014 - $1,988
-220 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$10.01 - $13.75 $2,202 - $3,025
220 New
220 $2,000
Q2 2020

Aug 10, 2020

SELL
$8.05 - $14.21 $1,771 - $3,126
-220 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$6.8 - $14.66 $1,496 - $3,225
220 New
220 $2,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $223M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.